bpc 157 torn meniscus A-D (A) An intraoperative image of a displaced tear is shown Prolotherapy for Meniscus Tears

Unsupervised biohacking with unregulated compounds can lead to serious health complications, muscle wasting, and endocrine disruption

These syndromes, specifically those induced by vessel occlusion and subsequently treated with BPC 157, include inferior caval vein syndrome (Vukojevic et al., 2018), Pringle maneuver ischemia, reperfusion (Kolovrat et al., 2020), BuddChiari syndrome (Gojkovic et al., 2020), superior sagittal sinus occlusion (Gojkovic et al., 2021a), and superior mesenteric artery and/or vein occlusion (Knezevic et al., 2021a

Quality Assurance & Stability

FAQ 1

Coding rules for new treatments delivered by intravitreal injection will be the same as those in place for currently approved treatments